Ownership Filing for Gao Wei R

2026-04-16SEC Filing 3 (0001104659-26-044404)

Gao Wei R, General Counsel at CASI Pharmaceuticals, Inc., reported a change in ownership on March 18, 2026. The filing details the ownership of various stock options, all of which are exercisable and grant the right to buy Ordinary Shares. These options have varying expiration dates between 2031 and 2034, with exercise prices of $1.93, $2.67, and $5.78. Some options are fully vested, while others are performance-based and exercisable upon achievement of performance targets, as indicated by footnotes F1 and F2.

Ticker mentioned:CASI